-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Lumateperone Tosylate in Insomnia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lumateperone Tosylate in Insomnia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lumateperone Tosylate in Insomnia Drug Details: Lumateperone tosylate (Caplyta) is a butyrophenone...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IA-14069 in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.IA-14069 in Rheumatoid Arthritis Drug Details:IA-14069 is under development for the treatment of rheumatoid arthritis, colitis...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GLM-101 in Congenital Disorder of Glycosylation Type I A
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. GLM-101 in Congenital Disorder of Glycosylation Type I A Drug Details: GLM-101 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – MPC-75IA in Pain
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MPC-75IA in Pain report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.MPC-75IA in PainDrug Details:MPC-75-IA (MSB-CAR001) is under development for the treatment of knee osteoarthritis,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBF-015 in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBF-015 in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBF-015 in Alzheimer's Disease Drug Details: MBF-015 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBF-015 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBF-015 in Parkinson's Disease report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBF-015 in Parkinson's Disease Drug Details: MBF-015 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MBF-015 in Huntington Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MBF-015 in Huntington Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MBF-015 in Huntington Disease Drug Details: MBF-015 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NA-0116 in Endometriosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NA-0116 in Endometriosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NA-0116 in EndometriosisDrug Details:NA-0116 is under development for the treatment of mild to moderate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TSC-101 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TSC-101 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.TSC-101 in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic...
-
Product Insights
Auto-Immune Diseases Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Auto-immune diseases Pipeline Market Report Overview Auto-immune diseases are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample. The auto-immune diseases pipeline market research report provides a comprehensive understanding of the pipeline products and their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories ·       The...